An article was published on ESMO Open by A. Vogel and M. Ducreux, titled “ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer“.
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared about this article on X, adding:
“ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer.
Added:
Pembrolizumab as a first-line option.
Novel targeted agents like T-DXd and zanidatamab in subsequent lines.”